Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis

Justin Loloi; Ian C. Gilchrist

doi:10.1002/ccd.27701

Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis

Justin Loloi, Ian C. Gilchrist

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Abstract

Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.

Original language	English (US)
Pages (from-to)	16-17
Number of pages	2
Journal	Catheterization and Cardiovascular Interventions
Volume	92
Issue number	1
DOIs	https://doi.org/10.1002/ccd.27701
State	Published - Jul 2018

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ccd.27701

Cite this

@article{65c8b3b288874aff9f5906b5e45f7eeb,

title = "Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis",

abstract = "Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.",

author = "Justin Loloi and Gilchrist, {Ian C.}",

note = "Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc.",

year = "2018",

month = jul,

doi = "10.1002/ccd.27701",

language = "English (US)",

volume = "92",

pages = "16--17",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "Wiley-Liss Inc.",

number = "1",

}

TY - JOUR

T1 - Hemophilia in the cath lab

T2 - Balancing the need to clot with the treatment of thrombosis

AU - Loloi, Justin

AU - Gilchrist, Ian C.

PY - 2018/7

Y1 - 2018/7

N2 - Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.

AB - Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.

UR - http://www.scopus.com/inward/record.url?scp=85051079951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051079951&partnerID=8YFLogxK

U2 - 10.1002/ccd.27701

DO - 10.1002/ccd.27701

M3 - Editorial

C2 - 30917221

AN - SCOPUS:85051079951

SN - 1522-1946

VL - 92

SP - 16

EP - 17

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 1

ER -

Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this